Hamburger Menu icon

Focused on Hematology,
Dedicated to Patients

Innovation

There are millions of patients whose lives are affected by
and suffer from hematologic diseases. From rare blood
disorders to widespread, chronic disorders, there are a
host of diseases that require creative, new approaches
and a willingness to pioneer new fields of biology.

learn more about our science

Impact

We are committed to turning scientific discoveries into
useful therapies that will have a meaningful impact on
the lives of patients and their families. We are pursuing
the development of treatments that will potentially save
lives, alleviate suffering and enable patients to lead
vibrant lives.

learn more about our pipeline

Inspiration

Our team of talented scientists and industry veterans draws 
motivation and meaning from the work we do and the patients 
we hope to help. We are also inspired by a shared drive, tireless 
dedication and desire to make a difference that brings us together 
as colleagues.

learn more about our team

In The News

Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update

Completed a successful end of Phase 2 meeting with the FDA for bitopertin in erythropoietic protoporphyria (EPP), reaching alignment on all proposed…


read more

Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.

Facility significantly increases future financial and operational flexibility Up to $200M available, with $30 million drawn at close and additional $80 million…


read more

Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

Oral presentation of complete data from Phase 1b trial of DISC-0974 in anemia of myelofibrosis (MF) Poster presentations across all programs, including…


read more